Dextromethorphan Bulk-Sale Limit Clears House, But Stalls In Senate
This article was originally published in The Tan Sheet
Executive Summary
House leadership made a lame duck priority of legislation to restrict sales and distribution of bulk forms of dextromethorphan (DXM), but HR 5280 did not get the same treatment in the Senate
You may also be interested in...
Bill To Restrict Bulk DXM Sales Reintroduced In House
Legislation reintroduced by Reps. Fred Upton, R-Mich., and Rick Larsen, D-Wash., Feb. 8 would restrict online sales of bulk dextromethorphan to entities registered with FDA, but does not propose methods of preventing abuse of OTC cough medicines
From Availability To Awareness: 2007 Brings Wide Range Of Goals For CHPA
The Consumer Healthcare Products Association looks to focus its efforts in 2007 on issues such as Rx-to-OTC switches, rising health care costs, consumer education and prevention of OTC abuse. CHPA President Linda Suydam recently spoke with "The Tan Sheet" about the association's accomplishments during 2006 and goals for the coming year
National Survey Results Add To DXM Abuse Concerns; CHPA Touts Education
Results from a national survey of illicit drug use by students provide a platform to address the problem of young people abusing over-the-counter cough and cold medicines containing dextromethorphan, the Consumer Healthcare Products Association said Dec. 21